Throughout the life sciences sector, the key trends of globalisation and digitalisation are providing new opportunities for growth and innovation. However, within development facilities, quality …

The end of the transition period is imminent. How can clinical trial sponsors and CROs ease the transition to CTIS? Soon, the one-year transition period …

Brexit has provided several challenges to the pharmaceutical industry that required robust actions and swift resolution in order to remain in compliance following the end …

The challenges of tackling international crime with national law enforcement are legion. John Binns, a partner in the Financial Crime team at BCL Solicitors considers …

A data-driven Regulatory ecosystem has huge potential, beyond the opportunity for operational improvement. However, Regulatory and product teams will need updated data skills to deliver …

Increasing Patient Access to HighQuality Topical Products The topical dermatology market, although niche, was estimated to be valued at approximately $20.4 billion in 2020.1 In …

If anyone had suggested only a few years ago that it is a realistic proposition to float a psychedelics company on any of the London …

Over the last two decades, significant advances in technology and new methodologies have made proteomics an extremely powerful tool for protein scientists, biologists and clinical …

When bringing a therapeutic to market, determining its potential to elicit an immune response and understanding the molecular and cellular interactions involved is essential. In …

The availability of a wide range of therapeutic biologics has revolutionised modern medicine. Whilst the majority of pharmaceutical drug products remain conventional, small-molecule medicines; the …